For Biopharma partners and venture capital investors

SEEKERS
Bioneex simplifies your drug candidates search and evaluation process

Access the most accurate, up-to-date, and reviewed information on drug candidates listed by drug development companies and connect with them directly

Bionex
Progress
Progress
Progress
Business development platform

STEP 1

Search drug candidates

Create your company profile and, through our advanced filtering, search and view drug candidates listed by drug development companies.

STEP 2

Receive messages

Set up your preferences and, based on them, receive messages from drug development companies on their drug candidates.

Bioneex
Bioneex

STEP 3

Become Member

After you create your company profile and set up your preferences, you can become a Member to have full access to the platform.

STEP 4

Access reviewed information

Access drug candidates detailed information reviewed by our scientific team, and contact drug development companies directly.

Bioneex
Bioneex

STEP 5

Matchmaking facilitations

By constantly reviewing drug candidates on the platform, our team will identify the most suitable for you and facilitate matchmaking introductions, connecting you directly with the drug development companies.

STEP 6

Deal flow automation

Stay competitive by receiving newly listed drug candidates and updates on your watchlist.

Bioneex

STEP 7

Deal

Reviewed drug candidates of your interest from direct source and direct contact with drug development companies will bring you to a deal.

Bioneex
250
Reviewed Listed Drug Candidates
200
Drug Development Companies
10
Weekly Listings

Already joined Bioneex

New drug development companies are joining and listing their drug candidates on Bioneex daily.
Become a Member and connect with them.

Seeker Starter Start for Free

Create company profile

Search and view drug candidates

Receive messages

Seeker Member $5,996 / year

Access reviewed drug candidates detailed information

Contact Providers

Matchmaking facilitations based on your preferences

Deal flow automation and updates on your watchlist